Merck Total Assets 1986-2025 | MRK

Merck total assets from 1986 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Merck total assets for the quarter ending June 30, 2025 were $117.523B, a 4.34% increase year-over-year.
  • Merck total assets for 2024 were $117.106B, a 9.78% increase from 2023.
  • Merck total assets for 2023 were $106.675B, a 2.28% decline from 2022.
  • Merck total assets for 2022 were $109.16B, a 3.28% increase from 2021.
Merck Annual Total Assets
(Millions of US $)
2024 $117,106
2023 $106,675
2022 $109,160
2021 $105,694
2020 $91,588
2019 $84,397
2018 $82,637
2017 $87,872
2016 $95,377
2015 $101,677
2014 $98,167
2013 $105,645
2012 $106,132
2011 $105,128
2010 $105,781
2009 $112,314
2008 $47,196
2007 $48,351
2006 $44,570
2005 $44,846
2004 $42,573
2003 $40,588
2002 $47,561
2001 $44,021
2000 $40,155
1999 $35,635
1998 $31,853
1997 $25,812
1996 $24,293
1995 $23,832
1994 $21,857
1993 $19,928
1992 $11,086
1991 $9,499
1990 $8,030
1989 $6,757
1988 $6,128
1987 $5,680
1986 $5,105
1985 $4,902
Merck Quarterly Total Assets
(Millions of US $)
2025-06-30 $117,523
2025-03-31 $115,122
2024-12-31 $117,106
2024-09-30 $117,532
2024-06-30 $112,630
2024-03-31 $105,849
2023-12-31 $106,675
2023-09-30 $106,727
2023-06-30 $104,469
2023-03-31 $107,796
2022-12-31 $109,160
2022-09-30 $107,081
2022-06-30 $107,095
2022-03-31 $106,668
2021-12-31 $105,694
2021-09-30 $93,494
2021-06-30 $90,688
2021-03-31 $90,847
2020-12-31 $91,588
2020-09-30 $89,800
2020-06-30 $90,615
2020-03-31 $84,913
2019-12-31 $84,397
2019-09-30 $83,331
2019-06-30 $83,965
2019-03-31 $82,354
2018-12-31 $82,637
2018-09-30 $85,130
2018-06-30 $85,040
2018-03-31 $86,041
2017-12-31 $87,872
2017-09-30 $91,676
2017-06-30 $92,804
2017-03-31 $96,561
2016-12-31 $95,377
2016-09-30 $98,335
2016-06-30 $96,475
2016-03-31 $98,755
2015-12-31 $101,677
2015-09-30 $101,232
2015-06-30 $102,582
2015-03-31 $108,345
2014-12-31 $98,167
2014-09-30 $101,808
2014-06-30 $97,860
2014-03-31 $108,460
2013-12-31 $105,645
2013-09-30 $106,419
2013-06-30 $106,876
2013-03-31 $106,200
2012-12-31 $106,132
2012-09-30 $106,301
2012-06-30 $105,525
2012-03-31 $105,509
2011-12-31 $105,128
2011-09-30 $106,534
2011-06-30 $106,195
2011-03-31 $105,865
2010-12-31 $105,781
2010-09-30 $107,840
2010-06-30 $106,171
2010-03-31 $111,594
2009-12-31 $112,314
2009-09-30 $48,739
2009-06-30 $49,407
2009-03-31 $46,543
2008-12-31 $47,196
2008-09-30 $48,546
2008-06-30 $47,458
2008-03-31 $47,041
2007-12-31 $48,351
2007-09-30 $45,701
2007-06-30 $44,183
2007-03-31 $42,993
2006-12-31 $44,570
2006-09-30 $43,719
2006-06-30 $43,479
2006-03-31 $43,418
2005-12-31 $44,846
2005-09-30 $43,831
2005-06-30 $43,006
2005-03-31 $43,117
2004-12-31 $42,573
2004-09-30 $42,874
2004-06-30 $41,855
2004-03-31 $41,665
2003-12-31 $40,588
2003-09-30 $42,589
2003-06-30 $50,008
2003-03-31 $48,954
2002-12-31 $47,561
2002-09-30 $47,337
2002-06-30 $45,960
2002-03-31 $45,475
2001-12-31 $44,021
2001-09-30 $43,706
2001-06-30 $41,749
2001-03-31 $40,226
2000-12-31 $40,155
2000-09-30 $38,008
2000-06-30 $37,443
2000-03-31 $35,778
1999-12-31 $35,635
1999-09-30 $34,588
1999-06-30 $33,210
1999-03-31 $32,289
1998-12-31 $31,853
1998-09-30 $31,157
1998-06-30 $27,494
1998-03-31 $26,400
1997-12-31 $25,812
1997-09-30 $25,898
1997-06-30 $25,628
1997-03-31 $24,732
1996-12-31 $24,293
1996-09-30 $23,982
1996-06-30 $23,246
1996-03-31 $23,984
1995-12-31 $23,832
1995-09-30 $22,446
1995-06-30 $21,827
1995-03-31 $21,720
1994-12-31 $21,857
1994-09-30 $21,120
1994-06-30 $20,707
1994-03-31 $19,987
1993-12-31 $19,928
1993-09-30 $12,625
1993-06-30 $12,326
1993-03-31 $11,541
1992-12-31 $11,086
1992-09-30 $10,905
1992-06-30 $10,147
1992-03-31 $9,663
1991-12-31 $9,499
1991-09-30 $9,193
1991-06-30 $8,642
1991-03-31 $8,282
1990-12-31 $8,030
1990-09-30 $7,772
1990-06-30 $7,349
1990-03-31 $6,905
1989-12-31 $6,757
1989-09-30 $6,506
1989-06-30 $6,143
1989-03-31 $6,409
1988-12-31 $6,128
1988-09-30 $5,931
1988-06-30 $5,709
1988-03-31 $5,773
1987-12-31 $5,680
1987-09-30 $5,788
1987-06-30 $5,474
1987-03-31 $5,295
1986-12-31 $5,105
1985-12-31 $4,902
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $270.018B $59.283B
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Johnson & Johnson (JNJ) United States $450.090B 16.68
Novo Nordisk (NVO) Denmark $424.453B 49.78
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12